Eloralintide
ENLIGHTEN-4
Eli Lilly · Phase 3 · Recruiting · Enrollment 900
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Eloralintide (YOA1) | Obesity or overweight | n/r | 75 | n/r | n/r |
| Placebo (YOA1) | Obesity or overweight | n/r | 75 | n/r | n/r |
| Eloralintide (YOA2) | Obesity or overweight | n/r | 75 | n/r | n/r |
| Placebo (YOA2) | Obesity or overweight | n/r | 75 | n/r | n/r |